golf - What was really interesting is on slide 34 is 87% prescription rate at 25% RRR and 90% at 30% RRR. My question then becomes what is the prescription rate at higher RRR's as 30% RRR is the minimum we need to even pass this trial. The Nichols et al chart in the presentation showed a 44% RRR rate in patients with the same parameters recruited in this trial from the ASSURE trial data. Secondary targets could have a positive effect on prescription rates as well. This story just keeps getting better and better. Let's just hope we pass the RRR benchmark on the Top Line announcement.

tada